Home » Topics » Regulatory » Patents

Patents
RSS

Yamanouchi and PT CarbaPharma describe cathepsin L inhibitor

Aug. 23, 1996

Antineoplastic agents from Japan Energy

Aug. 23, 1996

Farnesyl transferase inhibitors from Pierre Fabre

Aug. 23, 1996

Immunomodulating peptides from BioChem Pharma

Aug. 23, 1996

Taiho discloses antitumor nucleoside drugs

Aug. 23, 1996

Cyclooxygenase-2-inhibitors described by Japan Tobacco

Aug. 23, 1996

Cyclooxygenase-2 inhibitors from Merck Frosst

Aug. 23, 1996

Protease inhibitors from Sankyo

Aug. 23, 1996

SmithKline Beecham describes protease inhibitors

Aug. 23, 1996

Takeda describes cephem antibacterial agents

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...